Seguir
Pierre van der Bruggen
Pierre van der Bruggen
Dirección de correo verificada de uclouvain.be
Título
Citado por
Citado por
Año
A gene encoding an antigen recognized by cytolytic T lymphocytes on a human melanoma
P van der Bruggen, C Traversari, P Chomez, C Lurquin, E De Plaen, ...
Science 254 (5038), 1643-1647, 1991
47001991
Tumor antigens recognized by T lymphocytes
T Boon, JC Cerottini, B Van den Eynde, P van der Bruggen, A Van Pel
Annual review of immunology 12 (1), 337-365, 1994
16511994
Tumour antigens recognized by T lymphocytes: at the core of cancer immunotherapy
PG Coulie, BJ Van den Eynde, P Van Der Bruggen, T Boon
Nature Reviews Cancer 14 (2), 135-146, 2014
12662014
Human tumor antigens recognized by T lymphocytes.
T Boon, P van der Bruggen
The Journal of experimental medicine 183 (3), 725-729, 1996
11791996
Tumor regressions observed in patients with metastatic melanoma treated with an antigenic peptide encoded by gene MAGE‐3 and presented by HLA‐A1
M Marchand, N Van Baren, P Weynants, V Brichard, B Dréno, MH Tessier, ...
International journal of cancer 80 (2), 219-230, 1999
11131999
Human gene MAGE-3 codes for an antigen recognized on a melanoma by autologous cytolytic T lymphocytes.
B Gaugler, B Van den Eynde, P van der Bruggen, P Romero, JJ Gaforio, ...
The Journal of experimental medicine 179 (3), 921-930, 1994
9851994
Structure, chromosomal localization, and expression of 12 genes of the MAGE family
E De Plaen, C Traversari, JJ Gaforio, JP Szikora, C De Smet, F Brasseur, ...
Immunogenetics 40, 360-369, 1994
9801994
A nonapeptide encoded by human gene MAGE-1 is recognized on HLA-A1 by cytolytic T lymphocytes directed against tumor antigen MZ2-E.
C Traversari, P van der Bruggen, IF Luescher, C Lurquin, P Chomez, ...
The Journal of experimental medicine 176 (5), 1453-1457, 1992
8611992
T cell defined tumor antigens
BJ Van den Eynde, P Van Der Bruggen
Current opinion in immunology 9 (5), 684-693, 1997
8121997
BAGE: a new gene encoding an antigen recognized on human melanomas by cytolytic T lymphocytes
P Boël, C Wildmann, ML Sensi, R Brasseur, JC Renauld, P Coulie, ...
Immunity 2 (2), 167-175, 1995
8051995
Tumor‐specific shared antigenic peptides recognized by human T cells
P Van Der Bruggen, Y Zhang, P Chaux, V Stroobant, C Panichelli, ...
Immunological reviews 188 (1), 51-64, 2002
5872002
A peptide encoded by human gene MAGE‐3 and presented by HLA‐A2 induces cytolytic T lymphocytes that recognize tumor cells expressing MAGE‐3
P van der Bruggen, J Bastin, T Gajewski, PG Coulie, P Boël, C De Smet, ...
European journal of immunology 24 (12), 3038-3043, 1994
4651994
A CASP-8 mutation recognized by cytolytic T lymphocytes on a human head and neck carcinoma
S Mandruzzato, F Brasseur, G Andry, T Boon, P Bruggen
The Journal of experimental medicine 186 (5), 785-793, 1997
4241997
An antigenic peptide produced by peptide splicing in the proteasome
N Vigneron, V Stroobant, J Chapiro, A Ooms, G Degiovanni, S Morel, ...
Science 304 (5670), 587-590, 2004
4212004
Identification of MAGE-3 Epitopes Presented by HLA-DR Molecules to CD4+ T Lymphocytes
P Chaux, V Vantomme, V Stroobant, K Thielemans, J Corthals, R Luiten, ...
The Journal of experimental medicine 189 (5), 767-778, 1999
3291999
Autologous cytolytic T lymphocytes recognize a MAGE‐1 nonapeptide on melanomas expressing HLA‐Cw* 1601
PVD Bruggen, JP Szikora, P Boël, C Wildmann, M Somville, M Sensi, ...
European journal of immunology 24 (9), 2134-2140, 1994
2961994
Genes coding for tumor antigens recognized by cytolytic T lymphocytes.
A Pel, P Bruggen, PG Coulie, VG Brichard, B Lethé, B Eynde, ...
2941995
Direct isolation, phenotyping and cloning of low-frequency antigen-specific cytotoxic T lymphocytes from peripheral blood
PR Dunbar, GS Ogg, J Chen, N Rust, P van der Bruggen, V Cerundolo
Current Biology 8 (7), 413-416, 1998
2881998
Single-step antigen loading and activation of dendritic cells by mRNA electroporation for the purpose of therapeutic vaccination in melanoma patients
A Bonehill, AMT Van Nuffel, J Corthals, S Tuyaerts, C Heirman, ...
Clinical Cancer Research 15 (10), 3366-3375, 2009
2702009
Autologous human monocyte-derived dendritic cells genetically modified to express melanoma antigens elicit primary cytotoxic T cell responses in vitro: enhancement by …
T Tuting, CC Wilson, DM Martin, YL Kasamon, J Rowles, DI Ma, ...
The Journal of Immunology 160 (3), 1139-1147, 1998
2701998
El sistema no puede realizar la operación en estos momentos. Inténtalo de nuevo más tarde.
Artículos 1–20